Altimmune's Grant

Altimmune raised a round of funding on June 11, 2001. Investors include U.S. Navy.

Altimmune, formerly Vaxin, is an immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases.…

Articles about Altimmune's Grant: